---
title: "This Grand Canyon Education Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289181475.md"
description: "Truist Securities analyst Jasper Bibb initiated coverage on Grand Canyon Education Inc (NASDAQ:LOPE) with a Buy rating and a $200 price target, noting the stock closed at $148.59. Other initiations included Stifel's Buy on Enliven Therapeutics (ELVN), Raymond James' Strong Buy on FrontView REIT (FVR), and BTIG's Buy on Magnite (MGNI)."
datetime: "2026-06-09T11:06:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289181475.md)
  - [en](https://longbridge.com/en/news/289181475.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289181475.md)
generator: "portal-rs"
---

# This Grand Canyon Education Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Stifel analyst Dara Azar initiated coverage on **Enliven Therapeutics Inc** (NASDAQ:ELVN) with a Buy rating and announced a price target of $60. Enliven Therapeutics shares closed at $33.63 on Monday. See how other analysts view this stock.
-   Truist Securities analyst Jasper Bibb initiated coverage on **Grand Canyon Education Inc** (NASDAQ:LOPE) with a Buy rating and announced a price target of $200. Grand Canyon Education shares closed at $148.59 on Monday. See how other analysts view this stock.
-   Raymond James analyst RJ Milligan initiated coverage on **FrontView REIT In**c (NYSE:FVR) with a Strong Buy rating and announced a price target of $22. FrontView shares closed at $18.99 on Monday. See how other analysts view this stock.
-   BTIG analyst Tyler DiMatteo initiated coverage on **Magnite Inc** (NASDAQ:MGNI) with a Buy rating and announced a price target of $20. Magnite shares closed at $14.63 on Monday. See how other analysts view this stock.

Considering buying LOPE stock? Here’s what analysts think: 

*Photo via Shutterstock*

### Related Stocks

- [FVR.US](https://longbridge.com/en/quote/FVR.US.md)
- [ELVN.US](https://longbridge.com/en/quote/ELVN.US.md)
- [LOPE.US](https://longbridge.com/en/quote/LOPE.US.md)
- [MGNI.US](https://longbridge.com/en/quote/MGNI.US.md)
- [SF.US](https://longbridge.com/en/quote/SF.US.md)
- [TFC.US](https://longbridge.com/en/quote/TFC.US.md)
- [RJF.US](https://longbridge.com/en/quote/RJF.US.md)
- [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md)
- [SFB.US](https://longbridge.com/en/quote/SFB.US.md)
- [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md)
- [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md)
- [RJF-B.US](https://longbridge.com/en/quote/RJF-B.US.md)

## Related News & Research

- [Magnite (MGNI) Stock Looks Pricey On Cash Flow And Earnings](https://longbridge.com/en/news/295990247.md)
- [Enliven’s Lead Drug Could Disrupt The Leukemia Treatment Market, Analyst Says](https://longbridge.com/en/news/296259275.md)
- [Handelsbanken Fonder AB Buys New Shares in Enliven Therapeutics, Inc. $ELVN](https://longbridge.com/en/news/296460096.md)
- [Magnite President, Revenue & Market Strategy Sean Patrick Buckley disposes of 11,030 common shares worth $268,018.01](https://longbridge.com/en/news/296265663.md)
- [FrontView REIT, Inc. $FVR Shares Bought by Royal Bank of Canada](https://longbridge.com/en/news/296588791.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**